BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

740 related articles for article (PubMed ID: 24108280)

  • 21. Multicenter assessment of outcomes and complications associated with transforaminal versus anterior lumbar interbody fusion for fractional curve correction.
    Buell TJ; Shaffrey CI; Bess S; Kim HJ; Klineberg EO; Lafage V; Lafage R; Protopsaltis TS; Passias PG; Mundis GM; Eastlack RK; Deviren V; Kelly MP; Daniels AH; Gum JL; Soroceanu A; Hamilton DK; Gupta MC; Burton DC; Hostin RA; Kebaish KM; Hart RA; Schwab FJ; Ames CP; Smith JS;
    J Neurosurg Spine; 2021 Aug; 35(6):729-742. PubMed ID: 34416723
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Minimum 2-year analysis of sacropelvic fixation and L5-S1 fusion using S1 and iliac screws.
    Kuklo TR; Bridwell KH; Lewis SJ; Baldus C; Blanke K; Iffrig TM; Lenke LG
    Spine (Phila Pa 1976); 2001 Sep; 26(18):1976-83. PubMed ID: 11547195
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prospective, randomized, controlled trial of silicate-substituted calcium phosphate versus rhBMP-2 in a minimally invasive transforaminal lumbar interbody fusion.
    Nandyala SV; Marquez-Lara A; Fineberg SJ; Pelton M; Singh K
    Spine (Phila Pa 1976); 2014 Feb; 39(3):185-91. PubMed ID: 24253788
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Minimum 5-year analysis of L5-S1 fusion using sacropelvic fixation (bilateral S1 and iliac screws) for spinal deformity.
    Tsuchiya K; Bridwell KH; Kuklo TR; Lenke LG; Baldus C
    Spine (Phila Pa 1976); 2006 Feb; 31(3):303-8. PubMed ID: 16449903
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The use of recombinant human bone morphogenetic protein 2 (rhBMP-2) to promote spinal fusion in a nonhuman primate anterior interbody fusion model.
    Hecht BP; Fischgrund JS; Herkowitz HN; Penman L; Toth JM; Shirkhoda A
    Spine (Phila Pa 1976); 1999 Apr; 24(7):629-36. PubMed ID: 10209790
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Does Interbody Support at L5-S1 Matter in Long Fusions to the Pelvis?: A 5-year Analysis.
    Lara NJ; Chung AS; Lockwood D; Revella J; Crandall D; Chang MS
    Spine (Phila Pa 1976); 2021 Aug; 46(15):1014-1019. PubMed ID: 33428359
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Retrospective analysis of L5-S1 axial lumbar interbody fusion (AxiaLIF): a comparison with and without the use of recombinant human bone morphogenetic protein-2.
    Gerszten PC; Tobler WD; Nasca RJ
    Spine J; 2011 Nov; 11(11):1027-32. PubMed ID: 22122835
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Systematic Review of Lumbar Fusion Rates With and Without the Use of rhBMP-2.
    Galimberti F; Lubelski D; Healy AT; Wang T; Abdullah KG; Nowacki AS; Benzel EC; Mroz TE
    Spine (Phila Pa 1976); 2015 Jul; 40(14):1132-9. PubMed ID: 25955186
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Single-Level Minimally Invasive Transforaminal Lumbar Interbody Fusion versus Anterior Lumbar Interbody Fusion with Posterior Instrumentation at L5/S1.
    Jacob KC; Patel MR; Ribot MA; Parsons AW; Vanjani NN; Pawlowski H; Prabhu MC; Singh K
    World Neurosurg; 2022 Jan; 157():e111-e122. PubMed ID: 34610449
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Contribution of recombinant human bone morphogenetic protein-2 to the rapid creation of interbody fusion when used in transforaminal lumbar interbody fusion: a preliminary report. Invited submission from the Joint Section Meeting on Disorders of the Spine and Peripheral Nerves, March 2004.
    Mummaneni PV; Pan J; Haid RW; Rodts GE
    J Neurosurg Spine; 2004 Jul; 1(1):19-23. PubMed ID: 15291015
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Radiographic Appearance of Transforaminal Lumbar Interbody Fusion Performed With and Without Recombinant Human Morphogenetic Protein-2.
    Stensby JD; Kaliney RW; Alford B; Shen FH; Patrie JT; Fox MG
    AJR Am J Roentgenol; 2016 Mar; 206(3):588-94. PubMed ID: 26901016
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quantitative study of parathyroid hormone (1-34) and bone morphogenetic protein-2 on spinal fusion outcomes in a rabbit model of lumbar dorsolateral intertransverse process arthrodesis.
    Lina IA; Puvanesarajah V; Liauw JA; Lo SF; Santiago-Dieppa DR; Hwang L; Mao A; Bydon A; Wolinsky JP; Sciubba DM; Gokaslan Z; Holmes C; Witham TF
    Spine (Phila Pa 1976); 2014 Mar; 39(5):347-55. PubMed ID: 24365898
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Adjacent segment degeneration after lumbosacral fusion in spondylolisthesis: a retrospective radiological and clinical analysis].
    Zencica P; Chaloupka R; Hladíková J; Krbec M
    Acta Chir Orthop Traumatol Cech; 2010 Apr; 77(2):124-30. PubMed ID: 20447355
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Incidence and outcome of graft resorption in anterior lumbar interbody fusion: using femoral ring allografts and recombinant human bone morphogenetic protein-2.
    Kayanja M; Orr RD
    Spine (Phila Pa 1976); 2014 Mar; 39(5):374-80. PubMed ID: 24299714
    [TBL] [Abstract][Full Text] [Related]  

  • 35. rhBMP-2 for posterolateral instrumented lumbar fusion: a multicenter prospective randomized controlled trial.
    Hurlbert RJ; Alexander D; Bailey S; Mahood J; Abraham E; McBroom R; Jodoin A; Fisher C
    Spine (Phila Pa 1976); 2013 Dec; 38(25):2139-48. PubMed ID: 24296479
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical sequelae after rhBMP-2 use in a minimally invasive transforaminal lumbar interbody fusion.
    Singh K; Nandyala SV; Marquez-Lara A; Cha TD; Khan SN; Fineberg SJ; Pelton MA
    Spine J; 2013 Sep; 13(9):1118-25. PubMed ID: 24029138
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of cage geometry on sagittal alignment in instrumented posterior lumbar interbody fusion.
    Gödde S; Fritsch E; Dienst M; Kohn D
    Spine (Phila Pa 1976); 2003 Aug; 28(15):1693-9. PubMed ID: 12897494
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Surgical outcomes of degenerative spondylolisthesis with L5-S1 disc degeneration: comparison between lumbar floating fusion and lumbosacral fusion at a minimum 5-year follow-up.
    Liao JC; Chen WJ; Chen LH; Niu CC; Keorochana G
    Spine (Phila Pa 1976); 2011 Sep; 36(19):1600-7. PubMed ID: 21242863
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparison of radiographic and clinical outcomes of anterior lumbar interbody fusion performed with either a cellular bone allograft containing multipotent adult progenitor cells or recombinant human bone morphogenetic protein-2.
    Lee DD; Kim JY
    J Orthop Surg Res; 2017 Aug; 12(1):126. PubMed ID: 28841904
    [TBL] [Abstract][Full Text] [Related]  

  • 40. RhBMP-2-induced radiculitis in patients undergoing transforaminal lumbar interbody fusion: relationship to dose.
    Villavicencio AT; Burneikiene S
    Spine J; 2016 Oct; 16(10):1208-1213. PubMed ID: 27343729
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 37.